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The role of the sun in the aetiology of malignant melanoma is 
controversial.
In 1992 Schuster1 wrote provocatively, ‘Despite the lack of 
evidence of a causal link between sun exposure and melanoma, 
fear has been used shamelessly to frighten people out of the sun 
and into pigmented lesion clinics.’ He claimed that the main 
reason for the supposed increase in incidence of melanoma 
was that many lesions, previously regarded as benign, were 
being classified as malignant, and that melanomas were being 
invented not found. 
Risk factors
Many publications dealing with the role of the sun accentuate 
the view that melanocytic naevi are strongly associated with 
cutaneous melanoma, and that reducing sun exposure in very 
early life may be effective in reducing naevus prevalence and 
subsequent melanoma risk.2-4 Bauer et al.5 claimed that the 
number of melanocytic naevi is the most important risk factor 
for melanoma, and that total cumulative sun exposure seems to 
be the crucial environmental risk factor for the development of 
naevi. Therefore, reducing sun exposure reduces the number of 
naevi and consequently reduces melanoma risk.  Simplistically: 
less sun = fewer naevi = less melanoma. This evidence seems 
to point to the sun as the culprit. However, in total contrast, 
a compelling study from Iceland of airline personnel showed 
increased incidence of melanoma but no evidence of excessive 
sun exposure compared with controls.6 
Kennedy et al.7 claimed that painful sunburn before the age of 
20 years is associated with an increase in naevi and melanoma. 
The same authors7 nevertheless stated that lifetime sun expo-
sure appears to be associated with a lower risk of melanoma, 
but no reduction in the number of naevi. Rivers8 stated that 
outdoor workers have a decreased risk of melanoma compared 
with indoor workers, leading him to the idea that chronic sun 
exposure may even have a protective effect. Other authors9 
have found no differences between melanoma cases and con-
trols with regard to sunburn and sun exposure.
Christofers10 also questioned the role of the sun and sug-
gested that squamous cell carcinoma is due almost entirely to 
sun exposure, that basal cell carcinoma is partly due to sun 
exposure, and that melanoma is not due to sun exposure.
Demographic pathology and ethnicity 
In the darkly pigmented black people of South Africa, 80% 
of melanomas occur on the sole of the foot.11 In other parts of 
Africa the findings are similar.12 In populations of intermedi-
ate pigmentation, such as China,13 Japan,14 Saudi Arabia15 and 
India,16 there is a preponderance of acral lentiginous melano-
mas, predominantly on the sole of the foot. It is not implied that 
these population groups have a high incidence of melanoma. 
In some it is a rare tumour. It is clear that in China and India 
there is a preponderance of melanoma on the foot. However 
articles from Japan,14 Latin America17 and Saudi Arabia15 refer 
to the preponderance of acral lentiginous melanoma but do not 
specify the site. It is probable that the majority of these tumours 
occur on the sole of the foot, an area where ultraviolet light is 
not a factor. 
The frequency of melanoma on the sole of the foot varies 
according to skin pigmentation. The lowest frequency occurs 
in white-skinned people, an intermediate frequency in subjects 
with intermediate skin pigmentation, and the highest frequency 
in black-skinned people.13 The sun clearly plays no role in 
melanoma of the sole of the foot or sun-shielded sites such as 
the vulva.18
CONTROVERSIES IN MEDICINE
Does the sun play a role in the aetiology of malignant 
melanoma? 
A review
Charles Isaacson, Michèle Ramsay
Charles Isaacson, MD, FRCPath, DipClinPath, DPath: Emeritus 
Professor of Pathology, University of the Witwatersrand; National 
Health Laboratory Service.
Michèle Ramsay, PhD: Professor, Division of Human Genetics, 
School of Pathology, University of the Witwatersrand; NHLS.
Corresponding author: C Isaacson (charlesi@worldonline.co.za)
Pg 568-571.indd   568 7/27/07   9:24:59 AM
SAMJ FORUM
569
August 2007, Vol. 97, No. 8  SAMJ
Sunscreens
There is no definitive evidence that sunscreens protect people 
from developing melanoma. An analysis of 17 case-controlled 
studies concluded that the melanoma-protective potential of 
sunscreens could not be proved using the existing evidence.19 
Other authors20 have come to the same conclusion.
Among the authors who ascribe a role to the sun in the 
aetiology of melanoma are those who even suggest that use of 
sunscreens extends the duration of intentional sun exposure, 
thereby increasing melanoma risk.20,21 Other  authors22 have sug-
gested that sunscreens may absorb ultraviolet light and inhibit 
the skin’s inflammatory response, both dynamics promoting 
instead of protecting against melanoma. Most studies23,24 have 
not demonstrated a causative association between sunscreen 
use and melanoma.
Ultraviolet-A and ultraviolet-B 
irradiation
It is generally assumed that most of the sun’s damage results 
from UV-B irradiation. However current thought may suggest 
a major role for UV-A in inducing the genetic changes that ul-
timately lead to melanoma. No available commercial products 
adequately shield the skin from UV-A rays.25 On the basis of 
animal experiments other authors26 have maintained that UV-B 
irradiation is highly mutagenic and carcinogenic compared 
with UV-A.
Most writers concur that even though sunscreens block the 
mutagenic UV-B rays, they do not prevent melanoma. This casts 
doubt on the role of the sun in the aetiology of melanoma.
Eumelanin and phaeomelanin 
There are two distinct types of melanin in mammals – eumela-
nin and phaeomelanin.27 Eumelanin is brownish-black, and 
phaeomelanin reddish-yellow. Melanocytes of darker-skinned 
people show a preference for eumelanin, and melanocytes of 
light-skinned individuals show a preference for phaeomela-
nin.28 Eumelanin protects the skin against UV radiation. In 
contrast, phaeomelanin does not protect the skin against UV 
radiation,27 but actually contributes to UV-induced damage.28 
Eumelanin absorbs UV radiation well. Phaeomelanin has a 
limited ability to absorb radiation and therefore increases the 
risk of oxidative stress in the melanocytes. Dysplastic naevi 
synthesise less eumelanin and more phaeomelanin.29 The above 
findings suggest that high phaeomelanin levels in melanocytes 
may be of significance in the aetiology of melanoma.30
Recalling that blacks tend to develop melanoma on the sole 
of the foot and rarely elsewhere, an obvious question is whether 
the sole of the foot in black people contains a high phaeomela-
nin/eumelanin ratio compared with the rest of the body. We do 
not know the answer. No such study has been performed. 
Dysplastic naevi are also related to skin pigmentation.  Indi-
viduals with red hair and fair skin are more likely to develop 
dysplastic naevi.31
 Dysplastic naevi do not occur in black people.29 Is this be-
cause of a high eumelanin-phaeomelanin ratio? 
Albinism
Albinism is a condition in which melanogenesis is abnormal. 
It is divided into two categories, viz. tyrosinase-positive and 
tyrosinase-negative. Tyrosinase catalyses the formation of dopa 
(dihydroxyphenylalanine) from tyrosine.  Dopa is an intermedi-
ary in the formation of melanin.   Albinos in South Africa are 
tyrosinase-positive. Tyrosinase-negative albinos produce no 
tyrosinase, no dopa and no melanin. 
A Japanese study32 of the hairs of tyrosinase-positive albinos 
showed phaeomelanin only, unlike the hairs of the single 
tyrosinase-negative albino which contained neither eumelanin 
nor phaeomelanin. No studies have been performed on South 
African tyrosinase-positive albinos. It is, however, likely that 
they too produce phaeomelanin only. Pavel et al.29 stated that 
a raised phaeomelanin level increases the risk for melanoma. 
Is melanoma common in South African albinos who almost 
certainly produce phaeomelanin only? A study of 111 South 
African albinos33 showed that although nearly one-quarter 
had non-melanoma skin cancers, there was not a single case of 
melanoma. Other reports34-36 have confirmed that melanoma is 
rare in albinos. In other population groups, sun exposure and 
light colour constitute a major risk for melanoma, whereas in 
albinos sun exposure and light colour constitute a low risk for 
melanoma.37 This is indeed a challenging paradox.
A second paradox relates to the sun. If the sun is a factor in 
the number of acquired naevi, then albinos who are virtually 
unprotected from the sun should have large numbers of naevi. 
However, the number of pigmented naevi in albinos is similar 
to that found in white subjects.38 If the number of naevi is a risk 
factor for melanoma, it becomes difficult to explain the rarity of 
melanoma in albinos.
A remarkable observation by Wang et al.39 may contribute 
to understanding some of these paradoxes. They selected an 
experimental group of 469 patients with skin cancer, of whom 
238 had melanoma and 231 had non-melanoma cancers – 88 
squamous cell carcinomas and 143 basal cell carcinomas. The 
control group consisted of 329 cancer-free healthy subjects. 
Wang et al. exposed the white blood cells of the experimental 
and control groups to UV-B radiation and then analysed 
DNA repair activity.  They assessed mutagen sensitivity by 
measuring mutagen-induced chromatid breaks per cell in 
lymphocytes in vitro. They discovered that the frequency of UV-
B-induced chromatid breaks per cell was significantly higher 
in the non-melanoma skin cancers (i.e. squamous and basal 
cell carcinoma) than in control subjects. The striking finding 
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was that the frequency of UV-B-induced chromatid breaks in 
melanoma patients was the same as controls. It is clear from 
their study that an increased number of chromatid breaks 
indicative of a decreased ability to repair DNA damage caused 
by UV-B exposure, is a factor in the development of basal cell 
and squamous cell carcinoma, but not melanoma. 
They also state that sensitivity to UV-B radiation may interact 
with other known risk factors, such as light hair and skin 
colour, sunburn history, tanning ability and freckling to increase 
the risk of non-melanoma skin cancer. In contrast, UV-B sensi-
tivity does not increase the risk of melanoma. 
Wang et al. concluded that non-melanoma skin cancer and 
cutaneous malignant melanoma have different aetiologies and 
that UV radiation is not a major factor in the aetiology of malig-
nant melanoma.
However no research has answered the provocative question 
of why albinos, who are totally unprotected from the sun, de-
velop squamous and basal cell carcinomas but rarely melano-
mas. Is there a genetic factor protecting them from melanoma? 
In summary, with the exception of the above cases, the sun is 
not a major factor in the aetiology of malignant melanoma and 
genetic factors may well prove to be of greater significance. 
Genetic factors
Melanoma risk is 30 - 70 times higher in individuals with a 
significant family history compared with the general popula-
tion.40,41 Familial melanomas arise through a dominantly inher-
ited susceptibility to melanoma and many are characterised by 
germ-line mutations in specific genes. The lifetime risk of mela-
noma in individuals who carry these mutations is very high, 
but varies among geographical regions. Sporadic melanoma, 
however, accounts for well over 90% of melanoma cases.
Several of the well-known risk factors for melanoma have a 
genetic basis. Fair skin, red hair and freckling are genetically 
determined as complex traits with the input of many gene 
products in determining the final phenotype. The gene that has 
been studied most widely in this context is the melanocortin 1 
receptor gene (MC1R) which is considered a low-penetrance 
melanoma-predisposing gene.42 It is well documented that 
the presence of specific mutations confers an increased risk of 
melanoma42,43 and that MC1R is also a skin colour-independent 
risk factor for melanoma.44 In combination with mutations in 
the high-penetrance melanoma genes, the MC1R genotype can 
modify the risk of melanoma.45 It has also been shown that 
depending on which genotype is present at the albinism locus 
(OCA2), the risk of melanoma may be higher or lower, but 
that the effect is less than that of the MC1R locus.44 It has been 
suggested that MC1R screening should be included in a clinical 
assessment of melanoma risk.46 
Another risk factor for melanoma is mole count.47 This too 
has a complex genetic basis and has been calculated to be 42% 
heritable, with as much as 80% of the heritable component 
explained by a locus on chromosome 9p21.48 
Recent molecular investigations have revealed that there are 
distinct pathways for developing melanomas and that these 
can be distinguished by the number of chromosomal alterations 
(duplications and deletions), by the specific regions that are 
altered and by specific single gene mutations.49,50
 Genetic factors play a major role in familial melanoma, but 
a more subtle role in the common sporadic melanomas where 
an increased risk is present in individuals with combinations 
of alleles and genotypes that confer susceptibility. Many of 
the genetic variants that confer susceptibility, for example 
those in the genes that determine mole count and melanocyte 
proliferation and differentiation, have not yet been identified. 
The nature and frequency of these variants are likely to differ 
between populations, altering their relative genetic risk for 
melanoma.
Does the sun play a role in malignant melanoma? The jury is 
still out. 
  1.  Schuster S. Melanoma and sun exposure (Letter). Lancet 1995; 346: 1224.
  2.  Whiteman DC, Brown RM, Purdie DM, Hughes MC. Melanocytic naevi in very young 
children: the role of phenotype, sun exposure, and sun protection.   J Am Acad Dermatol 2005; 
52: 40-47.
  3. Harrison SL, Buettener PG, MacLennan R. The North Queensland ‘Sun-Safe Clothing’ Study: 
design and baseline results of a randomized trial to determine the effectiveness of sun-
protective clothing in preventing melanocytic naevi.  Am J Epidemiol 2005; 161: 536-545. 
  4.  Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of naevi in 5-6 year old 
European children. J Clin Epidemiol 2002; 55: 1075-1081.
  5.  Bauer J, Buttner P, Wiecker TS, Luther H, Garbe C.  Risk factors of incident melanocytic 
naevi: a longitudinal study in a cohort of 1 232 young German children.  Int J Cancer 2005; 
115: 121-126.
  6.  Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirwson B, Olafsson JH.  Risk factors for 
cutaneous malignant melanoma among air crews and a random sample of the population. 
Occup Environ Med 2003; 60: 815-820. 
  7.  Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. Leiden Skin Cancer 
Study. The influence of painful sunburn and lifetime sun exposure on the risk of actinic 
keratoses, seborrhoeic warts, melanocytic naevi, atypical naevi, and skin cancer.  J Invest 
Dermatol 2003; 120: 1087-1093.
  8.  Rivers JK.  Is there more than one road to melanoma? Lancet 2004; 363: 728-730. 
  9.  Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: risk factors 
and prognostic predictors.  Results of the Central Malignant Melanoma Registry of the 
German Dermatological Society. Pigment Cell Res 1992; Suppl 2, 285-294.
10.  Christofers AJ. Melanoma is not caused by sunlight.  Mutat Res 1998; 422: 113-117.
11.  Isaacson C. Pathology of a Black African Population: Current Topics in Pathology.  Heidelberg: 
Springer-Verlag, 1982. 
12.  Yakubu A, Mabogunje OA. Skin cancer in Zaria, Nigeria. Trop Doct 1995; 25: Suppl 1, 63-67.
13.  Collins RJ. Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungal sites. 
Cancer 1984; 54: 1482-1488.
14.  Jimbow K, Takahashi H, Miura S, Ikeda S, Kukita A.  Biological behaviour and natural course 
of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, 
subungual, and other acral malignant melanomas.  Am J Dermatopathol 1984; 6 Suppl: 43-53. 
15.  Al-Maghrabi JA, Al-Ghamdi AS, Elhakeem HA. Pattern of skin cancer in Southwestern Saudi 
Arabia. Saudi Med J 2004; 25: 776-779.
16.  Vijaykumar DK, Kanan RR, Chaturvedi HK. Plantar acral melanoma – an experience from a 
regional cancer centre, India. Indian J Cancer 1996; 33: 122-129.
17.  Jaramillo-Ayerbe F, Vallejo-Contreras J. Frequency and clinical and dermatoscopic features 
of volar and ungual pigmented melanocytic lesions: a study in school children of Manizales, 
Colombia.  Pediatr Dermatol 2004; 21: 218-222. 
18.  Ragnarsson-Olding BK. Primary malignant melanoma of the vulva – an aggressive tumour 
for modeling the genesis of non-UV light-associated melanomas.   Acta Oncol 2004; 43: 421-
435.
19.  Gefeller O, Pfahlberg A. Sunscreen use and melanoma:  a case of evidence-based prevention?  
Photodermatol Photoimmunol Photomed 2002; 18: 153-156. 
20.  Vainio H, Miller AB, Bianchini F. An international evaluation of cancer-preventative potential 
of sunscreens.  Int J Cancer 2000; 88: 838-842. 
21.  Autier P, Dore JF, Cattaruzza MS, et al. Sunscreen use, wearing clothes, and number of naevi 
in 6- to 7-year old European children. European Organisation for Research and Treatment of 
Cancer Melanoma Co-operative Group. J Natl Cancer Inst 1998; 90: 1837-1880.
22.  Chiang TM, Sayre RM, Dowdy JC, Wilkin NK, Rosenberg EW. Sunscreen ingredients inhibit 
inducible nitric oxide synthase (iNOS): a possible biochemical explanation for the sunscreen 
melanoma controversy. Melanoma Res 2005; 15: 3-6. 
23.  Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen 
use: epidemiological evidence.  Br J Dermatol 2002; 61: 24-30. 
24.   Bigby ME. The end of the sunscreen and melanoma controversy. Arch Dermatol 2004; 140: 
745-746.    
Pg 568-571.indd   570 7/27/07   9:25:00 AM
SAMJ FORUM
571
August 2007, Vol. 97, No. 8  SAMJ
25.  Landow K. Do sunscreens prevent skin cancer?  Postgrad Med 116: 3.
26.  Ichihashi M, Ueda M, Budiyanto A, et al. UV-induced skin damage. Toxicology 2003; 189: 21-
39. 
27.  Thody AJ, Higgins EM, Wakamatsu K, Ito S, Burchill SA, Marks JM.  Phaeomelanin as well 
as eumelanin is present in human epidermis. J Invest Dermatol 1991; 97: 340-344. 
28.  van Nieuwpoort F, Smit NP, Kolb R, van der Meulen H, Koerten H, Pavel S.   Tyrosine-
induced melanogenesis shows differences in morphologic and melanogenic preferences of 
melanosomes from light and dark skin types.  J Invest Dermatol 2004; 122: 1251-1255.
29.  Pavel S, van Nieuwpoort F, van der Meulen H, et al.  Disturbed melanin synthesis and 
chronic oxidative stress in dysplastic naevi. Eur J Cancer 2004; 40:1423-1430. 
30.  Salopek TG, Yamada K, Ito S, Jimbow K.  Dysplastic melanocytic nevi contain high levels of 
pheomelanin: quantative comparison of phaeomelanin/eumelanin levels between normal 
skin, common nevi, and dysplastic nevi. Pigment Cell Res 1991; 4: 172-179. 
31.  Vincensi MR, ďIschia M, Napolitano A, et al. Phaeomelanin versus eumelanin as a chemical 
indicator of ultraviolet sensitivity in fair-skinned subjects at high risk for melanoma: a pilot 
study. Melanoma Res 1998; 8: 53-58. 
32.  Saito N, Morishima T. Eumelanin and phaeomelanin contents in hairs of healthy 
Japanese patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-
methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism. Nippon Hifuka 
Gakkai Zasshi 1990; 100: 853-861.
33.  Kromberg JG, Castle D, Zwane EM, Jenkins T. Albinism and skin cancer in Southern Africa. 
Clin Genet 1989; 36: 43-52. 
34.  Yakubu A, Mabogunje OA. Skin cancer in African albinos. Acta Oncol 1993; 32: 621-622. 
35.  Pehamberger H, Honigsmann H, Wolff K.  Dysplastic nevus syndrome with multiple 
primary amelanotic melanomas in oculocutaneous albinism. J Am Acad Dermatol 1984; 11: 
731-735. 
36.  Ihn H, Nakamura K, Abe M, et al. Amelanotic metastatic melanoma in a patient with 
oculocutaneous albinism. J Am Acad Dermatol 1993; 28: 895-900. 
37.  Streutker CJ, McCready D, Jimbow K, From L.  Malignant melanoma in a patient with 
oculocutaneous albinism.  J Cutan Med Surg 2000; 4:149-152. 
38.  Bothwell JE. Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: a study in 
Black South Africans. Int J Dermatol 1997; 36: 831-836. 
39.  Wang LE, Xiong P, Strom SS, et al. In vitro sensitivity to ultraviolet B light and skin cancer 
risk: a case-control analysis. J Natl Cancer Inst 2005; 97: 1822-1831. 
40.  Kefford RF, Newton Bishop JA, Bergman W, Tucker MA. Counseling and DNA testing for 
individuals perceived to be genetically predisposed to melanoma: A consensus statement of 
the Melanoma Genetics Consortium. J Clin Oncol 1999; 17: 3245-3251.
41.  Masback A, Olsson H, Westerdahl J, et al. Clinical and histopathological features of malignant 
melanoma in germline CDKN2A mutation families. Melanoma Res 2002; 12: 549-557. 
42.  Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of 
melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 
2000; 66: 176-186.
43.  Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial 
melanoma in a Mediterranean population. J Natl Cancer Inst 2005; 97: 998-1007.
44.  Duffy DL, Box NF, Chen W, et al. Interactive effects of MC1R and OCA2 on melanoma risk 
phenotypes. Hum Mol Genet 2004; 13: 447-461.
45. Box NF, Duffy DL, Chen W, et al. MC1R genotype modifies risk of melanoma in families 
segregating CDKN2A mutations. Am J Hum Genet 2001; 69: 765-773. 
46.  Whiteman DC, Green AC. A risk prediction tool for melanoma? Cancer Epidemiol Biomarkers 
Prev 2005; 14: 761-763.
47.  Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, 
types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605-1611. 
48.  Zhu G, Duffy DL, Eldridge A, et al.  A major quantitative-trait locus for mole density is 
linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage 
and association analysis in twins and their sibs. Am J Hum Genet 1999; 65: 483-492. 
49.  Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma.  
N Engl J Med 2005; 353: 2135-2147.
50.  Whiteman DC, Brown RM, Purdie DM, Hughes MC. Melanocytic nevi, solar keratoses, and 
divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 806-812.
 
Q u i c k T i m e ™  a n d  a
 d e c o m p r e s s o r
a r e  n e e d e d  t o  s e e  t h i s  p i c t u r e .
THE 1ST PAN AFRICAN ANNUAL CONFERENCE AND EXHIBITION ON ICT & HEALTHCARE 
Grand Regency Hotel, Nairobi
18-20 September 2007
Theme “Advancing ICT for patient safety in Healthcare in Africa”.
SUPPORTED BY:
 
Healthcare 
REGISTRATION FEES:
Early bird before 20th August – US$ 310
Standard fee                            - US $ 350
For more details contact: John Mwangi
Tel: +254 20 4450115/6
Telefax: +254 20 4451655
Mobile: +254 721 860 228
Email: johnm@aitecafrica.com
Website: www.aitecafrica.com
Pg 568-571.indd   571 7/27/07   9:25:01 AM
